Loading...
Loading...
Contributors:
Dataset URI:
10.1021/acs.jcim.0c00792.s002Synthetic feasibility of compounds generated with de novo approaches is one of the main issues, which may limit their applicability. Many of the de novo generation approaches do not address this issue. Here, we studied the recently implemented chemically reasonable mutations approach (CReM) and the ways how one could indirectly control synthetic complexity of generated compounds and how this affected the target scores for Guacamol benchmark tasks. We found a clear trade-off between synthetic complexity and target scores and demonstrated that CReM-based solutions were competitive to reference approaches, which were explicitly biased by synthetic feasibility of generated compounds.
Keyword(s):
approach; Biochemistry; Biological Sciences not elsewhere classified; Chemical Sciences not elsewhere classified; complexity.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)